瑞聯新材(688550.SH):擬以4504萬元增加蒲城海泰新能源材料自動化生產項目的投資額
格隆匯5月11日丨瑞聯新材(688550.SH)公佈,公司於2022年5月11日召開第三屆董事會2022年第三次臨時會議及第三屆監事會2022年第二次臨時會議,審議通過了《關於使用自有資金增加蒲城海泰新能源材料自動化生產項目投資額的議案》,同意公司使用自有資金4504萬元增加蒲城海泰新能源材料自動化生產項目(“新能源項目”)新能源項目的投資額。公司獨立董事和監事會對上述事項發表了明確同意意見,保薦機構海通證券股份有限公司發表了無異議的專項核查意見。本議案尚需提交公司股東大會審議。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.